February 23, 2021
Nordic Nanovector launches a private placement of new shares
Media
February 23, 2021
Continued survival benefit in Targovax’s ONCOS-102 trial in mesothelioma at the 21-month follow-up
February 18, 2021
Oncopeptides Year-end Report 2020
February 18, 2021
Targovax ASA: Annual Report 2020
February 18, 2021
Nordic Nanovector Sees Significant Improvement in Patient Recruitment Rate in PARADIGME, its Single-arm Phase 2 Pivotal Trial with Betalutin® in R/R Follicular Lymphoma
February 18, 2021
Targovax ASA: Fourth quarter 2020 results
February 18, 2021
Nordic Nanovector ASA: Results for the Fourth Quarter and Full Year 2020
February 17, 2021
BONESUPPORT HOLDING AB (publ) – Publishes Full year report 2020
February 16, 2021
Strongbridge Biopharma plc Announces Promotion of Richard S. Kollender to President and Chief Financial Officer
February 16, 2021
Pulmonx to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021
